SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹211 Cr | ₹168 Cr | ₹69 Cr | ₹62 Cr | ₹28 Cr |
What is the latest Net Current Assets ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹211 Cr |
| Mar2024 | ₹168 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹62 Cr |
| Mar2017 | ₹28 Cr |
How is Net Current Assets of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹211 Cr | 25.20 | |
| Mar2024 | ₹168 Cr | 145.53 | |
| Mar2023 | ₹69 Cr | 11.35 | |
| Mar2022 | ₹62 Cr | 122.16 | |
| Mar2017 | ₹28 Cr | - | |
Compare Net Current Assets of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,200.4 Cr | -4.1% | -0.8% | -24.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -4.1% |
-0.8% |
-24.5% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses